Morpheus8 RF Microneedling

Morpheus8 fractional RF microneedling at MEDICOM Clinic Brno, combining insulated microneedle penetration with subdermal radiofrequency energy delivery to remodel collagen, tighten lax skin, and reduce texture irregularities. One of the most effective non-surgical skin tightening technologies available.

Morpheus8 at MEDICOM Clinic Brno represents the intersection of two proven aesthetic modalities: microneedling and radiofrequency energy. Where traditional microneedling delivers collagen induction solely through controlled dermal injury, and monopolar RF lifts by heating tissue from the surface, Morpheus8 combines both mechanisms in a single pass — using insulated microneedles to deliver RF energy precisely at a programmable depth below the skin surface, bypassing the epidermis and concentrating heat at the dermis-to-fat junction. The device uses a matrix of 24 insulated gold-coated microneedles that penetrate to depths of 1–8 mm depending on the treatment zone. Once at target depth, RF energy is emitted from the needle tips, creating thermal coagulation zones in the deep dermis and superficial subdermal fat. The insulation on the needle shafts protects the overlying epidermis from thermal damage, allowing high-energy delivery at depth without surface burns. This enables simultaneous treatment of facial laxity, jowl formation, submental fat, and textural irregularities — indications that previously required separate procedures. The biological response unfolds in two phases. Immediately, the RF heat denatures existing collagen fibres, causing them to contract — producing a degree of tissue tightening visible even in the first weeks post-treatment. Over 3–6 months, fibroblasts populate the treated zones and synthesise new collagen and elastin in response to both the RF thermal injury and the mechanical needle trauma. This delayed neocollagenesis produces the primary long-term tightening and texture improvement that distinguishes Morpheus8 from surface-only treatments. A standard course at MEDICOM involves three sessions spaced four to six weeks apart. Topical anaesthetic is applied 30–60 minutes before treatment to ensure comfort during needle penetration. Social downtime is typically 2–5 days of redness, pinpoint bleeding, and mild swelling. The treatment is suitable for skin types I–VI with appropriate energy parameter adjustments, and can be combined with PRP application post-treatment to support healing and enhance growth factor delivery into the freshly created microchannels.